Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Jan;2(1):69–72. doi: 10.1128/cdli.2.1.69-72.1995

Serotypes and subtypes of Neisseria meningitidis: results of an international study comparing sensitivities and specificities of monoclonal antibodies.

J T Poolman 1, P Kriz-Kuzemenska 1, F Ashton 1, W Bibb 1, J Dankert 1, A Demina 1, L O Frøholm 1, M Hassan-King 1, D M Jones 1, I Lind 1, et al.
PMCID: PMC170103  PMID: 7719916

Abstract

An international study supported by the World Health Organization comparing monoclonal antibodies for serotyping and serosubtyping of Neisseria meningitidis strains was performed and the results were assessed in 1992. A collection of 6 serotype-specific (1, 2a, 2b, 4, 14, and 15) and 12 serosubtype-specific (P1.1, P1.2, P1.4, P1.5, P1.6, P1.7, P1.9, P1.10, P1.12, P1.14, P1.15, and P1.16) monoclonal antibodies was provided to 11 participating laboratories throughout the world. Monoclonal antibodies were tested on 85 Neisseria meningitidis strains with known reference results. Whole-cell enzyme-linked immunosorbent assay was used for analysis in 10 of 11 laboratories. The sensitivities and specificities of individual serotype- and subtype-specific monoclonal antibodies were evaluated. Differences in individual laboratories and with individual monoclonal antibodies were assessed. Relatively large differences in sensitivities were achieved in individual laboratories. On the contrary, the specificities remained at high levels in all laboratories. The sensitivities of serotype-specific monoclonal antibodies ranged from 72.0 to 100%. Individual serosubtype-specific monoclonal antibodies showed sensitivities ranging from 64.1 to 98.1%. The most frequent reason for the incorrect results obtained with the monoclonal antibodies were false-negative results. The collaborative study demonstrated that some monoclonal antibodies are not very sensitive. Another study to define the most suitable monoclonal antibodies is planned.

Full Text

The Full Text of this article is available as a PDF (206.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdillahi H., Poolman J. T. Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. Microb Pathog. 1988 Jan;4(1):27–32. doi: 10.1016/0882-4010(88)90045-9. [DOI] [PubMed] [Google Scholar]
  2. Ashton F. E., Mancino L., Ryan A. J., Poolman J. T., Abdillahi H., Zollinger W. D. Serotypes and subtypes of Neisseria meningitidis serogroup B strains associated with meningococcal disease in Canada, 1977-1989. Can J Microbiol. 1991 Aug;37(8):613–617. doi: 10.1139/m91-104. [DOI] [PubMed] [Google Scholar]
  3. Bjune G., Høiby E. A., Grønnesby J. K., Arnesen O., Fredriksen J. H., Halstensen A., Holten E., Lindbak A. K., Nøkleby H., Rosenqvist E. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet. 1991 Nov 2;338(8775):1093–1096. doi: 10.1016/0140-6736(91)91961-s. [DOI] [PubMed] [Google Scholar]
  4. Calain P., Poolman J., Zollinger W., Sperber G., Bitter-Suermann D., Auckenthaler R., Hirschel B. Serological study of meningococcal isolates in Switzerland and France 1980-1986. Eur J Clin Microbiol Infect Dis. 1988 Dec;7(6):788–791. doi: 10.1007/BF01975051. [DOI] [PubMed] [Google Scholar]
  5. Frasch C. E., Zollinger W. D., Poolman J. T. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis. 1985 Jul-Aug;7(4):504–510. doi: 10.1093/clinids/7.4.504. [DOI] [PubMed] [Google Scholar]
  6. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Høiby E. A., Rosenqvist E., Frøholm L. O., Bjune G., Feiring B., Nøkleby H., Rønnild E. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann. 1991 Dec;14(2):147–156. [PubMed] [Google Scholar]
  8. Kuzemenská P., Bobák M. Sérotypizace a subtypizace kmenů Neisseria meningitidis izolovaných od nemocných v CSR v letech 1975-1986. Cesk Epidemiol Mikrobiol Imunol. 1990 Mar;39(2):78–87. [PubMed] [Google Scholar]
  9. Käyhty H., Poolman J., Abdillahi H., Sivonen A., Eskola J., Tarkka E., Peltola H. Sero- and subtypes of group B meningococci causing invasive infections in Finland in 1976-87. Scand J Infect Dis. 1989;21(5):527–535. doi: 10.3109/00365548909037881. [DOI] [PubMed] [Google Scholar]
  10. Poolman J. T., Abdillahi H. Outer membrane protein serosubtyping of Neisseria meningitidis. Eur J Clin Microbiol Infect Dis. 1988 Apr;7(2):291–292. doi: 10.1007/BF01963104. [DOI] [PubMed] [Google Scholar]
  11. Poolman J. T., Lind I., Jónsdóttir K., Frøholm L. O., Jones D. M., Zanen H. C. Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet. 1986 Sep 6;2(8506):555–558. doi: 10.1016/s0140-6736(86)90123-6. [DOI] [PubMed] [Google Scholar]
  12. Riou J. Y., Poolman J. T., Auriol J., Lomprez F., Guibourdenche M. Sero-subtyping of group B, C, Y and A meningococci isolated in France in 1988. Ann Biol Clin (Paris) 1990;48(4):227–231. [PubMed] [Google Scholar]
  13. Scholten R. J., Bijlmer H. A., Poolman J. T., Kuipers B., Caugant D. A., Van Alphen L., Dankert J., Valkenburg H. A. Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis. Clin Infect Dis. 1993 Feb;16(2):237–246. doi: 10.1093/clind/16.2.237. [DOI] [PubMed] [Google Scholar]
  14. de Moraes J. C., Perkins B. A., Camargo M. C., Hidalgo N. T., Barbosa H. A., Sacchi C. T., Landgraf I. M., Gattas V. L., Vasconcelos H. de G., Gral I. M. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet. 1992 Oct 31;340(8827):1074–1078. doi: 10.1016/0140-6736(92)93086-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES